Observation of the Reconstitution Process and Factors Influencing the Final Condition of Chemotherapy Patients in Private Hospitals
DOI:
https://doi.org/10.26630/jk.v15i2.4426Keywords:
Cancer; Chemotherapy; Handling of cytostatics.Abstract
Handling of cytostatic preparations is the aseptic handling of cancer drugs in ready-to-use packaging according to patient needs by trained pharmacists with control of environmental safety, officers, and drug preparations from toxic effects and contamination, using personal protective equipment. Resistant to handling cytostatics preparations, including preparation, mixing, handling of spills, and cytostatics waste management. This study aimed to determine the suitability of the handling of cytostatic preparations and the description of the use of chemotherapy drugs in cancer patients. This research was conducted by descriptive analytic observation, data on the handling of cytostatics preparations was obtained by observing directly in the chemotherapy drug mixing room, and data on the use of chemotherapy drugs were obtained retrospectively by looking at medical records and service sheets of mixing cytostatics preparations The population and sample of cytostatic preparation handling are all cytostatic preparation reconstitution processes that can be directly observed during the research period, while the sample for evaluating the use of chemotherapy drugs is the medical records of patients undergoing chemotherapy in 2018. The results obtained in handling cytostatic preparations in the preparation, mixing, and labeling stages are 100% to the guidelines, while the labeling stage is 86% appropriate. Evaluation of the type of use of chemotherapy drugs is known that the taxane drug class is the most widely used by 91.7%. The proper assessment of chemotherapy drugs in breast cancer patients is 92%, lung cancer is 100%, and uterine cancer is 0%. Evaluation of the correct dose of chemotherapy drugs obtained results of 0%. The conclusion of the chi-square statistical test analysis of the chemical cycle affects the patient's condition.
References
Agnessia, M., Sary, L., & Andoko. (2015). Faktor Risiko yang Berhubungan dengan Kanker Payudara di RSUD Pringsewu Tahun 2014. Jurnal Kesehatan Holistik, 9(1), 14–21.
Amelia, K., Rusli, D., & Hikmah, M. (2022). Evaluasi Penggunaan Obat dan Kesesuaian Dosis Kemoterapi Body Surface Area (BSA) Pasien Kanker Payudara di RSUD Sekayu. Pharmasipha: Pharmaceutical Journal of Islamic Pharmacy, 6(2), 56-62. https://doi.org/10.21111/pharmasipha.v6i2.8708
Connor, T., McLauchlan, R., & Vandenbroucke, J. (2007). Preface. Journal of Oncology Pharmacy Practice, 13(3_suppl), 1–81. https://doi.org/10.1177/1078155207082350
Donowati, M. W., Pramodhawardani, A. Y., & Lestari, I. (2013). Penggunaan obat sitostatika pada anak-anak yang melakukan kemoterapi di RSUP Dr. Sardjito Yogyakarta tahun 2010. Jurnal Farmasi Sains dan Komunitas (Journal of Pharmaceutical Sciences and Community), 10(1). https://e-journal.usd.ac.id/index.php/JFSK/article/view/84
Fauzi, H., Darsono, N. A., & . B. H. (2019). Analisis Kalkulasi Body Mass Index Dengan Pengolahan Citra Digital Berbasis Aplikasi Android. Jurnal Elektro Dan Telekomunikasi Terapan, 5(2), 693. http://journals.telkomuniversity.ac.id/jett/article/view/1395
Gunawan, S. G. (2011). Farmakologi dan Terapi Edisi ke-6. Depok: Badan penerbit FKUI.
Hidayat, A., Purwani, L. E., & Nugrohowati, N. (2020). Relationship of Chemotherapy and Energy Intake with Nutritional Status of Breast Cancer Patients Stage II-III at Fatmawati General Hospital in 2018–2019. Media Gizi Indonesia, 15(2), 110. https://doi.org/10.20473/mgi.v15i2.110-118
Husna, M. (2020). Stabilitas Dan Kompatibilitas Injeksi Propofol Sebagai Anestesi Umum Di Rumah Sakit : Tinjauan Stabilitas Dan Kompatibilitas Injeksi Propofol Sebagai Anestesi Umum Di Rumah Sakit : Tinjauan. [Undergraduate Thesis]. Yogyakarta: Faculty of Mathematics and Natural Sciences, Universitas Islam Indonesia. https://dspace.uii.ac.id/handle/123456789/28820
Husna, N. A. L. (2017). Evaluasi Kesesuaian Indikasi Penggunaan Obat Kemoterapi Di Rsup Dr. Sardjito Yogyakarta. [Undergraduate thesis]. Yogyakarta: Fakultas Farmasi: Universitas Gadjah Mada. https://etd.repository.ugm.ac.id/penelitian/detail/129491
Katzung, B. G., Masters, S. B., & Trevor, A. J. (2012). Farmakologi Dasar & Klinik. Jakarta: Penerbit Buku Kedokteran EGC.
Maria, I. L., Sainal, A. A., & Nyorong, M. (2017). Risiko Gaya Hidup Terhadap Kejadian Kanker Payudara Pada Wanita. Media Kesehatan Masyarakat Indonesia, 13(2), 157. https://doi.org/10.30597/mkmi.v13i2.1988
Mazumdar, M., Smith, A., Tong, william p., & robert j motzer. (2000). Brief Communications. Psychiatry (New York), 23(2), 215–217. https://doi.org/10.1521/00332747.1960.11023219
Ministry of Health RI. (2018). Pedoman Nasional Pelayanan Kedokteran Tata Laksana Kanker Payudara; Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/Menkes/414/2018, 1–111. Jakarta.
Ministry of Health RI. (2019). Petunjuk Teknis Standar Pelayanan Kefarmasian Di Rumah Sakit. Jakarta.
Ministry of Health RI. (2014). Pedoman Pencampuran Obat Suntik dan Penanganan Sediaan Sitostatika. Jakarta: Direktorat Pengelolaan dan Pelayanan Kefarmasian.
Mosteller, R. D. (1982). Simplified calculation of body-surface area. The New England Journal of Medicine, 1098.
Ningrum, M. P., & Rahayu, R. S. R. (2021). Determinan Kejadian Kanker Payudara pada Wanita Usia Subur (15-49 Tahun). Indonesian Journal of Public Health and Nutrition, 1(3), 362–370. http://journal.unnes.ac.id/sju/index.php/IJPHN
Nurhayati. (2018). Faktor-faktor risiko yang berhubungan dengan kejadian kanker payudara di rumah sakit umum daerah kota padangsidimpuan. Jurnal Warta Edisi 56, April.
Shukla, R., Singh, A., & Singh, K. K. (2024). Vincristine-based nanoformulations: a preclinical and clinical studies overview. Drug Delivery and Translational Research, 14(1), 1–16. https://doi.org/10.1007/s13346-023-01389-6
Simbolon, O. M. (2020). Evaluasi Penanganan Sediaan Sitotoksik Di Rumah Sakit Umum Abdul Wahab Sjahranie Samarinda. … : MEDFARM: Jurnal Farmasi dan Kesehatan, 9(2), 55-62.. https://doi.org/10.48191/medfarm.v9i2.35
Sukandar, E. Y., Hartini, S., & Rizkita, P. (2014). Evaluasi Reaksi Obat Merugikan pada Pasien Kemoterapi Kanker Payudara di Salah Satu Rumah Sakit di Bandung. Jurnal Ilmu Kefarmasian Indonesia, 12(2), 183–192.
Wells, B., Schwinghammer, T., DiPiro, J., & DiPiro, C. (2017). Pharmacotherapy Handbook. Washington DC: American College of Clinical Pharmacy
Wiguna, N., & Manuaba, I. (2012). Karakteristik pemeriksaan imunohistokimia pada pasien kanker payudara di rsup sanglah periode 2003-2012. Medika Udayana, 3(7), 1–13.
Yeo, W., Pang, E., Liem, G. S., Suen, J. J. S., Ng, R. Y. W., Yip, C. C. H., Li, L., Yip, C. H. W., & Mo, F. K. F. (2020). Menopausal symptoms in relationship to breast cancer-specific quality of life after adjuvant cytotoxic treatment in young breast cancer survivors. Health and Quality of Life Outcomes, 18(1), 1–9. https://doi.org/10.1186/s12955-020-1283-x
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Kiki Amelia
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish in this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
